These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9353747)

  • 1. Antibacterial efflux systems.
    Marshall NJ; Piddock LJ
    Microbiologia; 1997 Sep; 13(3):285-300. PubMed ID: 9353747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiantibiotic resistance caused by active drug extrusion in Pseudomonas aeruginosa and other gram-negative bacteria.
    Nakae T
    Microbiologia; 1997 Sep; 13(3):273-84. PubMed ID: 9353746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple antibiotic resistance and efflux.
    Nikaido H
    Curr Opin Microbiol; 1998 Oct; 1(5):516-23. PubMed ID: 10066525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of antimicrobial resistance in non-typable Haemophilus influenzae.
    Sánchez L; Leranoz S; Puig M; Lorén JG; Nikaido H; Viñas M
    Microbiologia; 1997 Sep; 13(3):309-14. PubMed ID: 9353749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance mechanisms: drug efflux across two membranes.
    Zgurskaya HI; Nikaido H
    Mol Microbiol; 2000 Jul; 37(2):219-25. PubMed ID: 10931319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.
    Hancock RE
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S93-9. PubMed ID: 9710677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux pumps and drug resistance in gram-negative bacteria.
    Ma D; Cook DN; Hearst JE; Nikaido H
    Trends Microbiol; 1994 Dec; 2(12):489-93. PubMed ID: 7889326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of efflux pumps in multidrug resistance of Gram-negative bacteria].
    Wiercińska O; Chojecka A; Kanclerski K; Rőhm-Rodowald E; Jakimiak B
    Med Dosw Mikrobiol; 2015; 67(1):55-62. PubMed ID: 26084076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
    Puzari M; Chetia P
    World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of efflux pump-based antibiotic resistance.
    Zgurskaya HI
    Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.
    Lee A; Mao W; Warren MS; Mistry A; Hoshino K; Okumura R; Ishida H; Lomovskaya O
    J Bacteriol; 2000 Jun; 182(11):3142-50. PubMed ID: 10809693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria.
    Saier MH; Paulsen IT; Sliwinski MK; Pao SS; Skurray RA; Nikaido H
    FASEB J; 1998 Mar; 12(3):265-74. PubMed ID: 9506471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistance efflux pumps - not just for resistance.
    Piddock LJ
    Nat Rev Microbiol; 2006 Aug; 4(8):629-36. PubMed ID: 16845433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.
    Neyfakh AA; Bidnenko VE; Chen LB
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4781-5. PubMed ID: 1675788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emr, an Escherichia coli locus for multidrug resistance.
    Lomovskaya O; Lewis K
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8938-42. PubMed ID: 1409590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system].
    Tian R; Yu LY; Xiao CL; Zuo L; Yao TJ; Yang LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):359-63. PubMed ID: 15379256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis.
    Sheridan RP; Chopra I
    Mol Microbiol; 1991 Apr; 5(4):895-900. PubMed ID: 1906966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.